Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-247550 (Ixabepilone) in Hepatobiliary Cancer
NCT00023946Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Aug 2001
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in hepatobiliary cancer (HBC), sponsored by National Cancer Institute. Started Aug 2001; status: terminated.
02
Drugs
ixabepilone
03
Conditions
hepatobiliary cancer (HBC)
Beyond the preview
Go deeper on NCT00023946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023946.